SQI Diagnostics (TSXV:SQD.H) - Prezzo delle azioni, notizie e analisi

SQD.H Panoramica delle azioni

A precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. Maggiori dettagli

SQD.H analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	0/6
Prestazioni passate	0/6
Salute finanziaria	0/6
Dividendi	0/6

Analisi del rischio

Non ha una capitalizzazione di mercato significativa ( CA$6M )

Patrimonio netto negativo

Le azioni sono altamente illiquide

Gli ultimi report finanziari risalgono a più di un anno fa

+ 2 più rischi

SQI Diagnostics Inc. Concorrenti

Scryb

CNSX:SCYB

CA$4.8m

ASEP Medical Holdings

CNSX:ASEP

CA$3.8m

Frequency Exchange

TSXV:FREQ

CA$6.6m

Evome Medical Technologies

TSXV:EVMT

CA$11.2m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per SQI Diagnostics
Prezzi storici delle azioni
Prezzo attuale dell'azione	CA$0.015
Massimo di 52 settimane	CA$0.02
Minimo di 52 settimane	CA$0.015
Beta	-0.38
1Variazione di 1 mese	n/a
Variazione a 3 mesi	n/a
Variazione di 1 anno	n/a
3Variazione a 3 anni	-90.91%
Variazione a 5 anni	-88.00%
Variazione dall'IPO	-99.23%

Notizie e aggiornamenti recenti

Recent updates

If You Had Bought SQI Diagnostics (CVE:SQD) Stock A Year Ago, You Could Pocket A 246% Gain Today

Dec 22

Is SQI Diagnostics (CVE:SQD) Using Debt Sensibly?

Nov 17

Rendimenti per gli azionisti

	SQD.H	CA Medical Equipment	CA Mercato
7D	0%	-1.4%	2.1%
1Y	n/a	2.0%	23.4%

Ritorno vs Industria: Dati insufficienti per determinare come si è comportato SQD.H rispetto al settore Canadian Medical Equipment.

Rendimento vs Mercato: Dati insufficienti per determinare la performance di SQD.H rispetto al mercato Canadian.

Volatilità dei prezzi

Is SQD.H's price volatile compared to industry and market?
SQD.H volatility
SQD.H Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	13.2%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Prezzo delle azioni stabile: SQD.H non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: Dati insufficienti per determinare la variazione della volatilità di SQD.H nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1999	n/a	Andrew Morris	www.sqidiagnostics.com

SQI Diagnostics Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di SQI Diagnostics con la sua capitalizzazione di mercato?
SQD.H statistiche fondamentali
Capitalizzazione di mercato	CA$6.11m
Guadagni(TTM)	-CA$19.14m
Ricavi(TTM)	CA$3.05m

2.0x

Rapporto P/S

-0.3x

Rapporto P/E

SQD.H è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
SQD.H Conto economico (TTM)
Ricavi	CA$3.05m
Costo del fatturato	CA$3.19m
Profitto lordo	-CA$140.00k
Altre spese	CA$19.00m
Guadagni	-CA$19.14m

Ultimi guadagni dichiarati

Mar 31, 2023

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.047
Margine lordo	-4.60%
Margine di profitto netto	-628.51%
Rapporto debito/patrimonio netto	-103.3%

Come si è comportato SQD.H nel lungo periodo?

Vedi performance storica e confronto

SQD.H Panoramica delle azioni

Analisi del rischio

SQI Diagnostics Inc. Concorrenti

CNSX:SCYB

CA$4.8m

CNSX:ASEP

CA$3.8m

TSXV:FREQ

CA$6.6m

TSXV:EVMT

CA$11.2m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

SQI Diagnostics Inc. Ordinary Shares to Be Deleted from OTC Equity

SQI Diagnostics Inc. Listing to Transfer to NEX Effective Feb. 20

Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc

SQI Diagnostics Expects its Common Shares to Continue to be Halted from Trading on Exchange and Ultimately Suspended and Delisted Following Completion of the Filing

SQI Diagnostics Inc. Announces Executive Changes

SQI Diagnostics Inc., Annual General Meeting, Jun 30, 2023

Recent updates

SQI Diagnostics Inc. Ordinary Shares to Be Deleted from OTC Equity

SQI Diagnostics Inc. Listing to Transfer to NEX Effective Feb. 20

Clive J. Beddoe Announces Resignation as Director of SQI Diagnostics Inc

SQI Diagnostics Expects its Common Shares to Continue to be Halted from Trading on Exchange and Ultimately Suspended and Delisted Following Completion of the Filing

SQI Diagnostics Inc. Announces Executive Changes

SQI Diagnostics Inc., Annual General Meeting, Jun 30, 2023

Second quarter 2023 earnings released: CA$0.009 loss per share (vs CA$0.007 loss in 2Q 2022)

Insufficient new directors

First quarter 2023 earnings released: CA$0.008 loss per share (vs CA$0.009 loss in 1Q 2022)

SQI Diagnostics Inc., Annual General Meeting, Apr 05, 2023

Full year 2022 earnings released: CA$0.048 loss per share (vs CA$0.031 loss in FY 2021)

SQI Installs Two Rali-Dx Systems in Toronto Hospitals to Fight the Growing Respiratory Health Crisis in Emergency Departments

SQI Diagnostics Inc. announced that it expects to receive CAD 1 million in funding

SQI Diagnostics Inc. announced that it expects to receive CAD 2 million in funding from Federal Economic Development Agency for Southern Ontario

SQI Diagnostics Announces Health Canada Approval of RALI-Dx Severity Triage Test

Third quarter 2022 earnings released: CA$0.012 loss per share (vs CA$0.002 loss in 3Q 2021)

Second quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

SQI Diagnostics (CVE:SQD) Has Debt But No Earnings; Should You Worry?

New York State Approves SQI Diagnostics' Exact Covid-19 Antibody Assay

First quarter 2022 earnings: EPS in line with analyst expectations despite revenue beat

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

SQI Diagnostics Systems Inc. signed a definitive agreement to acquire all of the assets underlying Precision Biomonitoring Inc businesses from Precision Biomonitoring Inc. for CAD 6.825 million

SQI Diagnostics Inc. announced that it expects to receive CAD 6 million in funding

Third quarter 2021 earnings released: CA$0.002 loss per share (vs CA$0.005 loss in 3Q 2020)

Is SQI Diagnostics (CVE:SQD) Weighed On By Its Debt Load?

FDA Stops Emergency Use Authorization Review of SQI Diagnostics Inc. RALI-Dx IL-6 Severity Triage Test for Covid-19 Patients

CEO & Director Robert Chioini has left the company

Second quarter 2021 earnings released: CA$0.011 loss per share (vs CA$0.009 loss in 2Q 2020)

Health Check: How Prudently Does SQI Diagnostics (CVE:SQD) Use Debt?

Independent Director recently sold CA$56k worth of stock

Are Insiders Buying SQI Diagnostics Inc. (CVE:SQD) Stock?

First quarter 2021 earnings released: CA$0.012 loss per share (vs CA$0.009 loss in 1Q 2020)

Director exercised options to buy CA$705k worth of stock.

Director recently bought CA$660k worth of stock

New 90-day high: CA$0.40

SQI Diagnostics Inc., Annual General Meeting, Mar 31, 2021

Full year 2020 earnings released: CA$0.032 loss per share (vs CA$0.045 loss in FY 2019)

Is SQI Diagnostics Inc. (CVE:SQD) Popular Amongst Insiders?

SQI Diagnostics Announces Patient Enrollment Begins for its COVID-19 HOME Antibody Test Clinical Study

New 90-day high: CA$0.28

Independent Director exercised options to buy CA$1.7m worth of stock.

If You Had Bought SQI Diagnostics (CVE:SQD) Stock A Year Ago, You Could Pocket A 246% Gain Today

Is SQI Diagnostics (CVE:SQD) Using Debt Sensibly?

Sqi Diagnostics Inc. Updates Clinical Progress on Novel Covid-19 Tests Under Development for U.S. Fda Regulatory Submission

Third quarter earnings released

SQI Diagnostics Inc. Announces Executive Changes

New 90-day high - CA$0.21

Rendimenti per gli azionisti

Volatilità dei prezzi

Informazioni sull'azienda

SQI Diagnostics Inc. Riepilogo dei fondamenti

2.0x

-0.3x

Guadagni e ricavi